Posted in | News | Gold | Mining Business

Glen Eagle Releases Report on Gold and Silver Production in June

Glen Eagle Resources Inc. ("Glen Eagle" or the "Company") is pleased to announce that it has produced during the first week of June thirty ounces (30) of gold and one thousand (1000) ounces of silver.

The daily plant throughput is set at 60 tons per day with mineralized material averaging 6.5 grams gold per tonne and 130 grams silver per tonne. Production cost was just under CDN $300 dollars per ounce and will remain as such for the coming months. Recovery stands at 70% with a possibility for further improvement. The Company is not entitled under NI 43-101 to make projections at this stage. It can only quote its production results once they are known. To keep its shareholders well informed, the Company will release the information about its production results on a monthly basis and through its quarterly financial statement.

Originally built to make a gold concentrate when the company entered into the transaction with Cobra Oro de Honduras, the plant has been redesigned over the last few months to deliver a dore bar as a finished product. The changes, although affected by unexpected delays, are now completed and as a result the plant has a steady production flow with a dore bar being produced on a regular basis. The referral date for ongoing production and future reference and analysis will be June 1 which marked the first significant pouring of dore bars by Cobra Oro.

By becoming a producer of precious metals, Glen Eagle has accomplished an important milestone which should be beneficial for its shareholders under normal circumstances.

Gilles Laverdiere, P.Geo., a qualified person under NI 43-101 has approved the technical content presented herein.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.